Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • New low calorie sugar...

    New low calorie sugar tagatose developed with help of bacteria

    Written by Hina Zahid Published On 2019-11-27T19:25:20+05:30  |  Updated On 27 Nov 2019 7:25 PM IST
    New low calorie sugar tagatose developed with help of bacteria

    Due to increasing concerns about excessive calories from added sugars in food, people especially diabetics seek a low-calorie alternative. Rare sugars such as tagatose which possesses a sweetness profile similar to sucrose but with much fewer calories is a promising low-calorie sweetener in the food industry.


    Scientists have developed new sugar called tagatose by using bacteria to derive it from fruits and dairy products. The new sugar has only 38 per cent of the calories of traditional table sugar. The researchers said tagatose may be safe for diabetics, and will not cause tooth cavities. The research findings have been published in the journal Nature Communications.


    The new sugar is approved by the US Food and Drugs Agency (FDA) as a food additive, and there have been no reports to date of the problems that many sugar substitutes have, such as a metallic taste, or links to cancer, according to the researchers at Tufts University in the US.


    While derived from fruits and dairy products, tagatose is not abundant and is difficult to extract from those sources, they said.


    The manufacturing process involves a conversion from more easily obtained galactose to tagatose and is highly inefficient, with yields that may reach only 30 per cent, the researchers explained.


    In the study, the researchers described a process that may unlock the commercial potential of this low-calorie, low-glycemic sugar.


    Assistant Professor Nikhil Nair and postdoctoral fellow Josef Bober, both from Tufts University, came up with an innovative way to produce the sugar using bacteria as tiny bioreactors that encapsulate the enzymes and reactants.


    Using this approach, they achieved yields up to 85 per cent.


    Although there are many steps from the lab to commercial production, yields this high could lead to large-scale manufacturing and getting tagatose on every supermarket shelf, the researchers said.


    The enzyme of choice to make tagatose from galactose is called L-arabinose isomerase (LAI).


    However, galactose is not the main target for the enzyme, so the rates and yields of the reaction with galactose are less than optimal.


    In a solution, the enzyme itself is not very stable, and the reaction can only push forward until about 39 per cent of the sugar is converted to tagatose at 37 degrees Celsius, and only up to 16 per cent at 50 degrees Celsius, before the enzyme degrades.


    The researchers looked to overcome each of those hurdles through biomanufacturing, using Lactobacillus Plantarum -- a food-safe bacterium -- to make large quantities of the LAI enzyme and keep it safe and stable within the confines of the bacterial cell wall.


    They found that when expressed in L. Plantarum, the enzyme kept converting galactose to tagatose and pushed the yield to 47 per cent at 37 degrees Celsius.


    However, now that the LAI enzyme was stabilised within the cell, it could increase yield to 83 per cent at the higher temperature of 50 degrees Celsius without degrading significantly, and it was producing tagatose at a much faster rate, the researchers said.


    To determine if they could push the reaction even faster, Nair and Bober examined what might still be limiting it.


    They found evidence that the transport of the starting material, galactose, into the cell was a limiting factor.


    To resolve that issue, they treated the bacteria with very low concentrations of detergents -- just enough to make their cell walls leaky, according to the researchers.


    The galactose was able to get in and tagatose released from the cells, allowing the enzyme to convert galactose to tagatose at a faster rate, shaving a couple of hours off the time needed to get to 85 per cent yield at 50 degrees Celsius, they said.


    For further reference log on to:

    Nature Communications
    BacteriaJosef Boberlow-calorie sugarNature CommunicationsNikhil NairTufts UniversityUS Food and Drugs Agency
    Source : Nature Communications

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok